Coronavirus mutations in New York, California raise concern | Science | In – depth reports on science and technology DW

Since health authorities have begun sequencing positive COVID-19 cases more carefully, that is, by genetically examining test results, they have also found more and more mutations.

Most of these mutations are negligible. But there are some variants that concern researchers and officials, in part because they are more contagious and because existing vaccines may be less effective in protecting them.

A border checkpoint on the Czech-German border

There is no longer freedom of movement. Some countries are trying to curb the spread of mutations by closing borders.

In addition to the variants identified in Britain, South Africa, and Brazil, there are two other variants of concern in the United States that appear to have evolved.

Fast diffusion

In November, researchers first noticed a mutation in New York City called B.1.526. Since then, this variant has spread rapidly to the metropolis and throughout the state. By mid-February, it had been detected in 12% of all New York samples that had a gene sequence.

This variant has also appeared in other countries such as Denmark.

A woman wearing a jogging face mask in front of the back of the Golden Gate Bridge

The California variant, CAL.20, is thought to be more contagious than the original virus, but not as dangerous as the British variant.

The so-called California variant, first detected in July 2020, has also spread rapidly. Meanwhile, the two similar types, B.1.427 and B.1.429, of the California variant can be found in approximately a quarter of the sequenced gene samples in California.

What do we know about the two US variants?

At the moment, we do not have exhaustive reliable data on these variants. The California variant, CAL.20C, is said to be more contagious than the original SARS-CoV-2 virus. In swabs taken from infected individuals, the viral load of the samples was found to almost double. But it is less infectious than the British mutant B.1.1.7, which has now been detected in a large number of countries, including Germany. Existing vaccines are thought to be slightly less effective against the California virus variant, but are still sufficient to protect patients from a severe course of COVID-19.

The New York virus variant, B.1.526, is similar to the South African variant, B.1.351, which has already been detected in more than 40 countries, and also shows similarity to the Brazilian variants, P.1 and P.2, which have been detected in more than 20 countries, most recently in the UK.

It is still unclear whether the New York variant is more contagious or dangerous and whether existing vaccines are still effective enough against this variant.

The new software helps with the search

Finding the respective variants is only possible if you know what to look for. Although we now know the SARS-CoV-2 genome, the virus has a length of 29,903 nucleotides, which is too long to quickly identify which variants could make it more infectious among the 611,000 genomes now stored at the base. of GISAID data. .

The mutations were found using new software called the Variant Database (VDB) developed at the California Institute of Technology in Pasadena, by a team led by Pamela Bjorkman. It focuses on changes in ear protein.

A man gets a swab test in Johannesburg

A mutation called E484K has been found in both the South African and Brazilian variants.

The potentially dangerous E484K mutation, present in B.1.351 and P.1, alters the spike protein receptor binding domain, and this is where they attack antibodies with the strongest neutralizing effect.

A cause for concern, but not panic

The tip of the ear protein is also altered in the New York variant. Understandably, this has caused some concern, Columbia University epidemiologist Wafaa El-Sadr told German public broadcaster ARD. “These changes may cause the spike protein to adhere better. Either the virus may reproduce more quickly. Or they may not be able to fight the antibodies through our vaccines,” he said.

But until there is detailed and robust data on U.S. variants, those observations remain speculative and there is no need to panic, said Dave Chokshi, commissioner of the New York City Department of Mental Health and Hygiene. So far, there is no evidence to show that it spreads faster, either to make people get sicker or to reduce the effectiveness of the vaccine, he said.

This article has been translated from German.

.Source